Bradykinin induced bronchoconstriction in guinea pigs and its modification by various agents.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000983:Antipyrine / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology*; D001980:Bronchi / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D004336:Drug Antagonism; D004357:Drug Synergism; D004983:Ethanolamines / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D010113:Oxyphenbutazone / Q000494:pharmacology; D010615:Phenacetin / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology*; D013442:Sulfinpyrazone / Q000494:pharmacology; D014309:Tripelennamine / Q000494:pharmacology
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D004983:Ethanolamines; D010643:Phenoxybenzamine; D014309:Tripelennamine; D006632:Histamine; D010615:Phenacetin; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin; D001920:Bradykinin; D000983:Antipyrine; D002746:Chlorpromazine; D013442:Sulfinpyrazone; D007213:Indomethacin; D008784:Methysergide